PDACSPortable Data Acquisition and Collection System
PDACSPacific Drugs and Alcohol Consumption Survey (New Zealand)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
(24) One might expect that bile duct carcinoma, which can be extremely well differentiated, would cause more diagnostic difficulty than PDAC; however, this was not the case in our study.
co-founder of the workshop and a PDAC past president, said of the program.
In their study, the Johns Hopkins team tested the vaccine in 39 people with pancreatic ductal adenocarcinomas (PDAC), the most common form of pancreatic cancer.
The cohort consisted of 17 PDACs, 3 mucinous adenocarcinomas, 2 adenocarcinomas not otherwise specified, and 1 neuroendocrine tumor.
Because PanIN is microscopic and often multifocal, it cannot be treated with surgical resection in the manner of a cyst, even though we now believe that most PDACs arise from PanIN lesions.
VEGF-A Assay.--Yip-Schneider et al (53) recently found markedly elevated VEGF-A in SCNs compared with pseudocysts, IPMNs, MCNs, and pancreatic ductal adenocarcinoma (PDAC).
(1) Pancreatobiliary carcinomas have a notoriously poor prognosis with an overall 5-year survival rate of less than 5% for pancreatic ductal adenocarcinoma (PDAC), (2-4) and few of these tumors are resectable at presentation because of the concomitant presence of metastasis or involvement of regional vital structures, such as the superior mesenteric or portal vasculature.
Pancreatic ductal adenocarcinoma (PDAC) accounts for 85% of cases and develops through a multistep acquisition of mutations, akin to the colorectal oncogenic model, although via different mutation types.
Perineural Invasion.--This is probably the most specific finding in PDAC and is detected in almost all resected PDACs.
Finally, ClinicalTrials.gov website was interrogated and "recruiting," "active, not recruiting," and "not yet recruiting" trials in PDAC were selected.
In PDAC, the observed collagen-mediated upregulation of MT1-MMP in the desmoplastic regions of the tumours promotes both tumour progression and gemcitabine resistance in a PDAC xenograft mouse model [6].